Secondary end points
pruritus
SECONDARY
Key secondary end points were the proportion of patients with ALP ≤1.0×ULN (normalization) at month 3 and the change in pruritus NRS from baseline at month 3 in patients with baseline pruritus NRS ≥4, which was considered symptomatic.